Rongxin Chen

Featured in: Favicon

sciencedirect.com Favicon

elsevier.com Favicon

Articles

Comparison analysis of ICIs and chemotherapy combined with or without lenvatinib as first-line treatment of unresectable intrahepatic cholangiocarcinoma | BMC Cancer | Full Text

1 month ago | bmccancer.biomedcentral.com | Miao Li |Rongxin Chen |Yan Wang

Patients diagnosed with unresectable ICC Between Jan 2022 and Sep 2023, who received either dual therapy (ICIs plus chemotherapy) or triple therapy (ICIs plus chemotherapy and Lenvatinib) as first-line treatment in Zhongshan Hospital, Fudan University were enrolled in the study.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →